Dynamics of the bacterial gut microbiota in preterm and term infants after intravenous amoxicillin/ceftazidime treatment

Динамика бактериальной микробиоты кишечника у недоношенных и доношенных младенцев после внутривенного лечения амоксициллином/цефтазидимом
Jan Knol, Clara Belzer, Rocío Martín, Romy Daniëlle Zwittink, Ingrid B. Renes, Obbe F. Norbruis, Diny van Zoeren‐Grobben, Richard A. van Lingen, Liesbeth J. Groot Jebbink
2020-05-07

BifidobacteriumEnterococcusamoxicillin/ceftazidime treatmentgut microbiotapreterm infants
BACKGROUND: It is important to understand the consequences of pre-emptive antibiotic treatment in neonates, as disturbances in microbiota development during this key developmental time window might affect early and later life health outcomes. Despite increasing knowledge regarding the detrimental effect of antibiotics on the gut microbiota, limited research focussed on antibiotic treatment duration. We determined the effect of short and long amoxicillin/ceftazidime administration on gut microbiota development during the immediate postnatal life of preterm and term infants. METHODS: Faeces was collected from 63 (pre) term infants at postnatal weeks one, two, three, four and six. Infants received either no (control), short-term (ST) or long-term (LT) postpartum amoxicillin/ceftazidime treatment. RESULTS: Compared to control infants, ST and LT infants' microbiota contained significantly higher abundance of Enterococcus during the first two postnatal weeks at the expense of Bifidobacterium and Streptococcus. Short and long antibiotic treatment both allowed for microbiota restoration within the first six postnatal weeks. However, Enterococcus and Bifidobacterium abundances were affected in fewer ST than LT infants. CONCLUSIONS: Intravenous amoxicillin/ceftazidime administration affects intestinal microbiota composition by decreasing the relative abundance of Escherichia-Shigella and Streptococcus, while increasing the relative abundance of Enterococcus and Lactobacillus species during the first two postnatal weeks. Thriving of enterococci at the expense of bifidobacteria and streptococci should be considered as aspect of the cost-benefit determination for antibiotic prescription.
1
Antibiotic-treated infants showed increased Enterococcus abundance, accompanied by reduced Bifidobacterium and Streptococcus compared with untreated controls.
2
Both short- and long-term antibiotic treatment permitted microbiota restoration within six postnatal weeks.
3
Intravenous amoxicillin/ceftazidime altered gut microbiota composition in preterm and term infants during the first two postnatal weeks.
4
Microbiota disruptions involving Enterococcus and Bifidobacterium affected fewer infants after short-term than long-term treatment, supporting treatment duration as an important consideration.
5
Treatment decreased Escherichia-Shigella and Streptococcus while increasing Enterococcus and Lactobacillus relative abundances.

Gut microbiota of preterm and term infants during the immediate postnatal period after intravenous amoxicillin/ceftazidime treatment

The effects of short- versus long-term intravenous amoxicillin/ceftazidime treatment on gut microbiota composition, bacterial abundances, and restoration during the first six postnatal weeks

Publication Details
Publication Date
2020-05-07
Journal
Publisher
ISSN
Cited by
32
Access Type
Author Information
Authors
Jan Knol
Clara Belzer
Rocío Martín
Romy Daniëlle Zwittink
Ingrid B. Renes
Obbe F. Norbruis
Diny van Zoeren‐Grobben
Richard A. van Lingen
Liesbeth J. Groot Jebbink
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%